Who
Jonathan D. Root
Director
Company insider
Files Form 4 as: Director, Omada Health; Director, Edgewise Therapeutics; Director, Carlsmed; Director and 10% owner, Inari Medical; Director and 10% owner, eFFECTOR Therapeutics; Director and 10% owner, ARS Pharmaceuticals; Director and 10% owner, OncoMed Pharmaceuticals; 10% owner, Inspire Medical Systems.
In numbers
- Trades disclosed
- 313
- Buys
- 9
- Sells
- 32
- Bought
- $16.8M
- Sold
- $12.2M
- Companies
- 14
- Companies where not an officer
- 14
- First trade
- 10 Aug 2006
- Last trade
- 5 Oct 2026
- Last filed
- 7 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Oct 2026filed 7 Oct 2026 | OMDA Omada HealthProviders & Facilities | SEC FORM 4 Code A | —694 at $0.00 | filing |
| 5 Jul 2026filed 7 Jul 2026 | OMDA Omada HealthProviders & Facilities | SEC FORM 4 Code A | —820 at $0.00 | filing |
| 5 Jul 2026filed 7 Jul 2026 | OMDA Omada HealthProviders & Facilities | SEC FORM 4 Code A | —820 at $0.00 | filing |
| 16 Jun 2026filed 18 Jun 2026 | OMDA Omada HealthProviders & Facilities | SEC FORM 4 Code A | —10,882 at $0.00 | filing |
| 16 Jun 2026filed 18 Jun 2026 | OMDA Omada HealthProviders & Facilities | SEC FORM 4 Code A | —10,882 at $0.00 | filing |
| 5 Jun 2026filed 17 Jul 2026 | EWTX Edgewise Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,377 at $0.00 | filing |
| 5 Jun 2026filed 17 Jul 2026 | EWTX Edgewise Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,377 at $0.00 | filing |
| 3 Jun 2026filed 22 Jun 2026 | CARL CarlsmedMedical Devices | SEC FORM 4 Code A | —13,698 at $0.00 | filing |
| 3 Jun 2026filed 22 Jun 2026 | CARL CarlsmedMedical Devices | SEC FORM 4 Code A | —13,698 at $0.00 | filing |
| 5 Apr 2026filed 7 Apr 2026 | OMDA Omada HealthProviders & Facilities | SEC FORM 4 Code A | —882 at $0.00 | filing |
| 5 Apr 2026filed 7 Apr 2026 | OMDA Omada HealthProviders & Facilities | SEC FORM 4 Code A | —882 at $0.00 | filing |
| 5 Jan 2026filed 7 Jan 2026 | OMDA Omada HealthProviders & Facilities | SEC FORM 4 Code A | —915 at $0.00 | filing |
| 5 Jan 2026filed 7 Jan 2026 | OMDA Omada HealthProviders & Facilities | SEC FORM 4 Code A | —915 at $0.00 | filing |
| 2 Dec 2025filed 4 Dec 2025 | OMDA Omada HealthProviders & Facilities | SEC FORM 4 Code J | —167,748 at $0.00 | filing |
| 2 Dec 2025filed 4 Dec 2025 | OMDA Omada HealthProviders & Facilities | SEC FORM 4 Code J | —4,571,769 at $0.00 | filing |
| 2 Dec 2025filed 4 Dec 2025 | OMDA Omada HealthProviders & Facilities | SEC FORM 4 Code J | —146,257 at $0.00 | filing |
| 5 Oct 2025filed 7 Oct 2025 | OMDA Omada HealthProviders & Facilities | SEC FORM 4 Code A | —657 at $0.00 | filing |
| 24 Jul 2025filed 24 Jul 2025 | CARL Carlsmedoption or derivative · Medical Devices | SEC FORM 4 Code C | —2,948,794 | filing |
| 24 Jul 2025filed 24 Jul 2025 | CARL Carlsmedoption or derivative · Medical Devices | SEC FORM 4 Code C | —825,135 | filing |
| 24 Jul 2025filed 24 Jul 2025 | CARL Carlsmedoption or derivative · Medical Devices | SEC FORM 4 Code C | —531,877 | filing |
News
Analyzing AxoGen (NASDAQ:AXGN) & AtriCure (NASDAQ:ATRC)ATRC · tickerreport.com · 18 Oct 2026MKS (NASDAQ:MKSI) and MaxLinear (NASDAQ:MXL) Head to Head ReviewMXL · themarketsdaily.com · 17 Oct 2026MaxLinear (NASDAQ:MXL) Shares Down 9.5% – What's Next?MXL · tickerreport.com · 14 Oct 2026MaxLinear, Inc.: MaxLinear Accelerates AI-Powered Broadband with Topaz and Intelligent Network Innovations at Network X 2026MXL · finanznachrichten.de · 13 Oct 2026Comparing Carlsmed (NASDAQ:CARL) and Establishment Labs (NASDAQ:ESTA)CARL · dailypolitical.com · 13 Oct 2026Edgewise Therapeutics Doses First Patient In Phase 2 HFpEF Trial; Stock DownEWTX · rttnews.com · 8 Oct 2026
0 headlines in the last 90 days name Jonathan D. Root; 6 articles from the last 14 days about the 5 companies they traded most, at most three about any one of them.